Reunion Neuroscience Stock Cash And Equivalents
| REUNDelisted Stock | USD 1.12 0.01 0.90% |
Reunion Neuroscience fundamentals help investors to digest information that contributes to Reunion Neuroscience's financial success or failures. It also enables traders to predict the movement of Reunion Stock. The fundamental analysis module provides a way to measure Reunion Neuroscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Reunion Neuroscience stock.
Reunion |
Reunion Neuroscience Company Cash And Equivalents Analysis
Reunion Neuroscience's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Reunion Neuroscience Cash And Equivalents | 48.13 M |
Most of Reunion Neuroscience's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Reunion Neuroscience is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
CompetitionIn accordance with the recently published financial statements, Reunion Neuroscience has 48.13 M in Cash And Equivalents. This is 94.14% lower than that of the Healthcare sector and 89.24% lower than that of the Biotechnology industry. The cash and equivalents for all United States stocks is 98.22% higher than that of the company.
Reunion Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Reunion Neuroscience's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Reunion Neuroscience could also be used in its relative valuation, which is a method of valuing Reunion Neuroscience by comparing valuation metrics of similar companies.Reunion Neuroscience is currently under evaluation in cash and equivalents category among its peers.
Reunion Fundamentals
| Return On Equity | -0.86 | |||
| Return On Asset | -0.27 | |||
| Current Valuation | (13.96 M) | |||
| Shares Outstanding | 11.72 M | |||
| Shares Owned By Insiders | 34.39 % | |||
| Shares Owned By Institutions | 50.65 % | |||
| Number Of Shares Shorted | 114.9 K | |||
| Price To Book | 0.49 X | |||
| Price To Sales | 2.80 X | |||
| Gross Profit | (4.29 M) | |||
| EBITDA | (17.15 M) | |||
| Net Income | (48.49 M) | |||
| Cash And Equivalents | 48.13 M | |||
| Cash Per Share | 4.14 X | |||
| Total Debt | 3.37 M | |||
| Current Ratio | 47.74 X | |||
| Book Value Per Share | 1.82 X | |||
| Cash Flow From Operations | (27.92 M) | |||
| Short Ratio | 1.92 X | |||
| Earnings Per Share | (2.51) X | |||
| Target Price | 9.39 | |||
| Number Of Employees | 16 | |||
| Beta | 4.21 | |||
| Market Capitalization | 13.01 M | |||
| Total Asset | 29.74 M | |||
| Retained Earnings | (91.48 M) | |||
| Working Capital | 21.24 M | |||
| Z Score | -3.04 | |||
| Net Asset | 29.74 M |
About Reunion Neuroscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Reunion Neuroscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Reunion Neuroscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Reunion Neuroscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Reunion Neuroscience
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Reunion Neuroscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reunion Neuroscience will appreciate offsetting losses from the drop in the long position's value.Moving against Reunion Stock
| 0.78 | NVO | Novo Nordisk AS | PairCorr |
| 0.78 | REGN | Regeneron Pharmaceuticals | PairCorr |
| 0.77 | NONOF | Novo Nordisk AS | PairCorr |
| 0.71 | QSAM | Qsam Biosciences | PairCorr |
| 0.66 | EPGG | Empire Global Gaming | PairCorr |
The ability to find closely correlated positions to Reunion Neuroscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Reunion Neuroscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Reunion Neuroscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Reunion Neuroscience to buy it.
The correlation of Reunion Neuroscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Reunion Neuroscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Reunion Neuroscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Reunion Neuroscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Consideration for investing in Reunion Stock
If you are still planning to invest in Reunion Neuroscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reunion Neuroscience's history and understand the potential risks before investing.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |